Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
2.895
+0.095 (3.39%)
Sep 18, 2025, 1:04 PM EDT - Market open

Akebia Therapeutics Statistics

Total Valuation

AKBA has a market cap or net worth of $767.59 million. The enterprise value is $801.00 million.

Market Cap767.59M
Enterprise Value 801.00M

Important Dates

The next estimated earnings date is Thursday, November 6, 2025, before market open.

Earnings Date Nov 6, 2025
Ex-Dividend Date n/a

Share Statistics

AKBA has 265.15 million shares outstanding. The number of shares has increased by 16.95% in one year.

Current Share Class 265.15M
Shares Outstanding 265.15M
Shares Change (YoY) +16.95%
Shares Change (QoQ) +12.21%
Owned by Insiders (%) 2.02%
Owned by Institutions (%) 42.98%
Float 259.80M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 3.19
Forward PS 2.98
PB Ratio 25.20
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 3.93
EV / EBITDA 34.31
EV / EBIT 200.30
EV / FCF n/a

Financial Position

The company has a current ratio of 1.98, with a Debt / Equity ratio of 6.70.

Current Ratio 1.98
Quick Ratio 1.77
Debt / Equity 6.70
Debt / EBITDA 6.91
Debt / FCF n/a
Interest Coverage 0.14

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) 0.88%
Return on Invested Capital (ROIC) 1.69%
Return on Capital Employed (ROCE) 1.76%
Revenue Per Employee $1.13M
Profits Per Employee -$201,569
Employee Count181
Asset Turnover 0.72
Inventory Turnover 1.68

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +108.03% in the last 52 weeks. The beta is 1.02, so AKBA's price volatility has been similar to the market average.

Beta (5Y) 1.02
52-Week Price Change +108.03%
50-Day Moving Average 3.37
200-Day Moving Average 2.63
Relative Strength Index (RSI) 38.07
Average Volume (20 Days) 3,559,608

Short Selling Information

The latest short interest is 27.09 million, so 10.22% of the outstanding shares have been sold short.

Short Interest 27.09M
Short Previous Month 24.81M
Short % of Shares Out 10.22%
Short % of Float 10.43%
Short Ratio (days to cover) 6.73

Income Statement

In the last 12 months, AKBA had revenue of $203.73 million and -$36.48 million in losses. Loss per share was -$0.16.

Revenue203.73M
Gross Profit 169.55M
Operating Income 4.00M
Pretax Income -40.44M
Net Income -36.48M
EBITDA 23.35M
EBIT 4.00M
Loss Per Share -$0.16
Full Income Statement

Balance Sheet

The company has $137.31 million in cash and $195.90 million in debt, giving a net cash position of -$58.59 million or -$0.22 per share.

Cash & Cash Equivalents 137.31M
Total Debt 195.90M
Net Cash -58.59M
Net Cash Per Share -$0.22
Equity (Book Value) 29.22M
Book Value Per Share 0.11
Working Capital 115.94M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$2.40 million and capital expenditures -$148,000, giving a free cash flow of -$2.55 million.

Operating Cash Flow -2.40M
Capital Expenditures -148,000
Free Cash Flow -2.55M
FCF Per Share -$0.01
Full Cash Flow Statement

Margins

Gross margin is 83.22%, with operating and profit margins of 1.96% and -17.91%.

Gross Margin 83.22%
Operating Margin 1.96%
Pretax Margin -17.91%
Profit Margin -17.91%
EBITDA Margin 11.46%
EBIT Margin 1.96%
FCF Margin n/a

Dividends & Yields

AKBA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -16.95%
Shareholder Yield -16.95%
Earnings Yield -4.91%
FCF Yield -0.34%

Analyst Forecast

The average price target for AKBA is $6.90, which is 138.34% higher than the current price. The consensus rating is "Strong Buy".

Price Target $6.90
Price Target Difference 138.34%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (5Y) 25.49%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

AKBA has an Altman Z-Score of -4.88 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -4.88
Piotroski F-Score 4